Skip to main content

GABELLI FUNDS LLC

Position in HALO — Halozyme Therapeutics, Inc.

CIK 1081407 Rye, NY

Position in HALO

as of Mar 31, 2026 · filed May 14, 2026
Position Value
$2,985,906
-$4,127,704 QoQ
Shares Held
46,200
-56.3% QoQ
Ownership
0.039%
of shares outstanding
% of Portfolio
0.02%
of 13F equity value
Holder Rank
not a current holder
Holding Since
Dec 2021
17 quarters on record
Voting authority Sole 100% Shared 0% None 0%

Common Shares in HALO Over Time

Shares Held

Position Value (USD)

Position in Biotechnology

Healthcare · as of Mar 31, 2026

GABELLI FUNDS LLC holds $96,689,277 across 29 Biotechnology names. HALO ranks #8 (3.1% of the industry book) .

# Ticker Company Shares Value (USD) Open
8 HALO
Halozyme Therapeutics, Inc.
This page
46,200 $2,985,906

All Filings in HALO

Export CSV
17 filing rows on record
Report Date Value (USD) Shares
2026-03-31 $2,985,906 46,200
2025-12-31 $7,113,610 105,700
2025-09-30 $8,965,301 122,243
2025-06-30 $6,567,160 126,243
2025-03-31 $7,413,445 116,180
2024-12-31 $5,748,817 120,243
2024-09-30 $6,424,789 112,243
2024-06-30 $6,539,764 124,900
2024-03-31 $5,085,000 125,000
2023-12-31 $4,250,400 115,000
2023-09-30 $3,447,091 90,238
2023-06-30 $3,020,429 83,738
2023-03-31 $3,197,954 83,738
2022-12-31 $1,014,299 17,826
2022-09-30 $593,100 15,000
2022-06-30 $660,000 15,000
2021-12-31 $201,050 5,000